{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-001983","form_type":"8-K","ticker":null,"cik":"0001411906","company_name":"Ampio Pharmaceuticals, Inc.","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.109342+00:00","generated_at":"2026-06-05T08:32:43.309866+00:00","sec_items":["1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ampio terminates at-the-market equity offering agreement with H.C. Wainwright","bullets":["Termination notice issued Feb 26, 2024; effective March 6, 2024.","Filed post-effective amendment to withdraw all unsold shares from registration.","ATM program originally established September 18, 2023.","No securities sold under the program since termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-001983","json":"https://secwatch.observer/filing/0001558370-24-001983.json","markdown":"https://secwatch.observer/filing/0001558370-24-001983.md","text":"https://secwatch.observer/filing/0001558370-24-001983.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411906/000155837024001983/0001558370-24-001983-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411906/000155837024001983/ampe-20240226x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T08:32:43.309866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5290a1fc15c6132116c83e0f5142b56ff99c1cfc","claim":"Ampio Pharmaceuticals, Inc. terminated ATM Agreement with H.C. Wainwright & Co., LLC (effective 2024-02-26).","evidence_excerpt":"On February 26, 2024, Ampio Pharmaceuticals, Inc. (the “Company”) provided a notice to H.C. Wainwright & Co., LLC to terminate that certain At The Marketing Offering Agreement, dated September 18, 2023, by and between the Company and H.C. Wainwright & Co., LLC (the “ATM Agreement”), establishing an at-the-market equity distribution program for the offer and sale from time to time shares of the Company’s common stock, par value $0.0001.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411906/000155837024001983/0001558370-24-001983-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"H.C. Wainwright & Co., LLC"},{"label":"Effective","value":"2024-02-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}